Ftse Mib
34.219,50
-0,28%
DAX
20.247,50
-0,03%
S&P 500
6.050,61
-0,39%
NASDAQ
20.109,06
-0,32%
Bitcoin
103.932,57
-2,09%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Assembly Biosciences Inc (ASMB) Assembly Biosciences Inc (ASMB) Notizie

Assembly Biosciences Inc

ASMB
14,28
0,00 (0,00%)
18 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
13/12/202422:05EDGAR2Form 8-K - Current report
26/11/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/11/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202421:22EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
07/11/202422:50EDGAR2Form 8-K - Current report
07/11/202422:42EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/11/202422:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202422:14EDGAR2Form 8-K - Current report
07/11/202422:05GLOBEAssembly Biosciences Reports Third Quarter 2024 Financial..
09/10/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/9/202414:05EDGAR2Form 8-K - Current report
23/9/202414:00GLOBEAssembly Biosciences Reports Positive Interim Phase 1a..
08/8/202422:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/8/202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202422:10EDGAR2Form 8-K - Current report
08/8/202422:05GLOBEAssembly Biosciences Reports Second Quarter 2024 Financial..
05/8/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/8/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/7/202414:00GLOBEAssembly Biosciences Presents New Preclinical Data..
08/7/202416:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202422:07EDGAR2Form 8-K - Current report
18/6/202422:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18/6/202414:00GLOBEAssembly Biosciences Doses First Participant in Phase 1b..
17/6/202414:00GLOBEAssembly Biosciences Announces $12.6 Million in Equity..
10/6/202414:00GLOBEAssembly Biosciences Doses First Participant in Phase 1a/b..
05/6/202414:00GLOBEAssembly Biosciences Presents New Data Highlighting..
03/6/202422:05EDGAR2Form 8-K - Current report
30/5/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202414:00GLOBEAssembly Biosciences to Present Data at Upcoming..
08/5/202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202422:10EDGAR2Form 8-K - Current report
08/5/202422:05GLOBEAssembly Biosciences Reports First Quarter 2024 Financial..
28/3/202421:05GLOBEAssembly Biosciences Reports Fourth Quarter and Year End..
08/2/202414:00GLOBEAssembly Biosciences Announces Effective Date of Reverse..
02/2/202422:05EDGAR2Form 8-K - Current report
19/1/202417:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202422:05EDGAR2Form 8-K - Current report
04/1/202414:00GLOBEAssembly Biosciences Provides Anticipated Development..
21/12/202322:06EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
21/12/202322:01EDGAR2Form DEF 14A - Other definitive proxy statements
Apertura: Min: Max:
Chiusura: 14,28

La tua Cronologia

NASDAQ
ASMB
Assembly Biosciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network